2021

Breast cancer cells create collagen shields to protect themselves from the immune system

A study published in Nature with the participation of IDIBELL and ICO shows that a protein on the surface of mammary tumor cells binds to extracellular collagen and aligns it to block the entry of immune cells.

Breast cancer cells create collagen shields to protect themselves from the immune system Read More »

Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery

Dr. Joan Fabregat Prous, a principal investigator of the IDIBELL hepato-biliary-pancreatic pathology research group and head of the section of the General and Digestive Surgery Service of the Bellvitge University Hospital, received the “Pere Virgili Award” on October 14th. The event took place at the Royal Academy of Medicine of Catalonia.

Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery Read More »

A team of neuroscientist from IDIBELL performed an experiment about musical curiosity at Sónar+D

Music plays a key role in our lives: it has the inherent ability to evoke a wide range of emotions and feelings and it is used as a powerful mood regulator. But strong individual differences have been observed in the intrinsic motivation to look for new music and enjoy it. For example, while some people

A team of neuroscientist from IDIBELL performed an experiment about musical curiosity at Sónar+D Read More »

A study identifies risk factors for severe COVID-19 in HIV patients

Results show that people with HIV who suffer from other chronic diseases, have a detectable viral load in their blood, were born outside Spain and/or are over 65 years old, could have a higher risk of suffering from severe COVID-19.

A study identifies risk factors for severe COVID-19 in HIV patients Read More »

A study estimates the number of people at high risk of developing lung cancer in Spain

The results of this study have been published in the scientific journal Archives of Bronconeumology and it has been lead by members of the Early Cancer Detection group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan nstitute of Oncology (ICO).

A study estimates the number of people at high risk of developing lung cancer in Spain Read More »

Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients

One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.

Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients Read More »

Identified two drugs with antitumor activity in preclinical models of malignant pleural cancer

Researchers from IDIBELL and ICO describe that CDK4 and CDK6 inhibitors stop tumor cell proliferation and expand the life expectancy in animal models.

Identified two drugs with antitumor activity in preclinical models of malignant pleural cancer Read More »

Scroll to Top